› Forums › General Melanoma Community › Triall on patients with melanoma spread to their brain.
- This topic has 30 replies, 9 voices, and was last updated 10 years, 1 month ago by
BrianP.
- Post
-
- February 5, 2015 at 9:03 am
New drug to be trialled on melanoma patients in world first on-melanoma-patients-in-world-first/story-
IN a world-first, a drug will be trialled on Victorian patients with melanoma so advanced it has spread to their brain.
The principal investigator, Associate Professor Georgina Long, of the MIA Poche Centre, said this was the first trial of immunotherapy treatment nivolumab on patients with melanoma in their brain.
- Replies
-
-
- February 5, 2015 at 11:17 am
Thanks Jerry, Well timed post for me! Just shot my Onc a note asking about a fit for my plan B. Much appreciated.
-
- February 5, 2015 at 11:17 am
Thanks Jerry, Well timed post for me! Just shot my Onc a note asking about a fit for my plan B. Much appreciated.
-
- February 5, 2015 at 11:17 am
Thanks Jerry, Well timed post for me! Just shot my Onc a note asking about a fit for my plan B. Much appreciated.
-
- February 5, 2015 at 1:16 pm
Great news, they used to exclude patients with brain mets from PD1 trials. It seems there are 3 legs: Opdivo/nivolumab, Opdivo/nivolumab + Yervoy/ipilimumab and radiation (not clear if it's with Opdivo).
My wife's not in a trial but she progressed on the BRAF/MEK combo and developed 12 brain mets, either in the "free fall" period before moving onto PD1 or whilst already on PD1. Anyway, she was allowed to continue and is now having Keytruda/pembrolizumab (4th infusion yesterday), had 5 days of whole brain radiation and today had radiation of her hips (bone mets).
Will keep everyone posted – even though she's not on a trial,
Rick
-
- February 5, 2015 at 1:16 pm
Great news, they used to exclude patients with brain mets from PD1 trials. It seems there are 3 legs: Opdivo/nivolumab, Opdivo/nivolumab + Yervoy/ipilimumab and radiation (not clear if it's with Opdivo).
My wife's not in a trial but she progressed on the BRAF/MEK combo and developed 12 brain mets, either in the "free fall" period before moving onto PD1 or whilst already on PD1. Anyway, she was allowed to continue and is now having Keytruda/pembrolizumab (4th infusion yesterday), had 5 days of whole brain radiation and today had radiation of her hips (bone mets).
Will keep everyone posted – even though she's not on a trial,
Rick
-
- February 5, 2015 at 1:16 pm
Great news, they used to exclude patients with brain mets from PD1 trials. It seems there are 3 legs: Opdivo/nivolumab, Opdivo/nivolumab + Yervoy/ipilimumab and radiation (not clear if it's with Opdivo).
My wife's not in a trial but she progressed on the BRAF/MEK combo and developed 12 brain mets, either in the "free fall" period before moving onto PD1 or whilst already on PD1. Anyway, she was allowed to continue and is now having Keytruda/pembrolizumab (4th infusion yesterday), had 5 days of whole brain radiation and today had radiation of her hips (bone mets).
Will keep everyone posted – even though she's not on a trial,
Rick
-
- February 5, 2015 at 1:54 pm
Thanks for the post Jerry!!!! I have been following " Jennifer's Journey " on facebook, she is one of the luck ones to get into the trial in Australia and has just finished her 4th dose of Nivolumab. She is friends with one of the great leaders in Melamona awareness in Australia (Jay Allen). He has been one of the main fighters to get sun tanning beds banned in Australia. I wish every one the best, in their Melanoma journey's. Ed
-
- February 5, 2015 at 1:54 pm
Thanks for the post Jerry!!!! I have been following " Jennifer's Journey " on facebook, she is one of the luck ones to get into the trial in Australia and has just finished her 4th dose of Nivolumab. She is friends with one of the great leaders in Melamona awareness in Australia (Jay Allen). He has been one of the main fighters to get sun tanning beds banned in Australia. I wish every one the best, in their Melanoma journey's. Ed
-
- February 5, 2015 at 1:54 pm
Thanks for the post Jerry!!!! I have been following " Jennifer's Journey " on facebook, she is one of the luck ones to get into the trial in Australia and has just finished her 4th dose of Nivolumab. She is friends with one of the great leaders in Melamona awareness in Australia (Jay Allen). He has been one of the main fighters to get sun tanning beds banned in Australia. I wish every one the best, in their Melanoma journey's. Ed
-
- February 5, 2015 at 8:01 pm
Yay! YAY! YAY! And a few….It's about time!!!! (s)!!!! Here's some data I've been YELLING to back up the approach if one is interested!! Thanks for sharing, Jerry!
Celeste
-
- February 5, 2015 at 8:01 pm
Yay! YAY! YAY! And a few….It's about time!!!! (s)!!!! Here's some data I've been YELLING to back up the approach if one is interested!! Thanks for sharing, Jerry!
Celeste
-
- February 10, 2015 at 7:12 am
Is this keytruda? -
- February 10, 2015 at 7:12 am
Is this keytruda? -
- February 10, 2015 at 6:29 pm
Crystal,
If I understand your question you are wondering in the first post by Jerry if the drug referred to as nivolumab is Keytruda. If that's your question the answer is no.
Kinda confusing but most drugs start out with what I like to call their chemical name and then later they get a commercial name. There are two big players on the anti-PD1 scene right now. One is BMS's drug which is nivolumab and is now being marketed as Opdivo. The second is Merck's pembrolizumab which is now being marketed as Keytruda. Both drugs are anti-PD1 inhibitors and both drugs have had very similar results on patients with maybe a slight edge to Keytruda but it's probably to early to say for sure. Hope this answers your question.
Brian
-
- February 10, 2015 at 6:29 pm
Crystal,
If I understand your question you are wondering in the first post by Jerry if the drug referred to as nivolumab is Keytruda. If that's your question the answer is no.
Kinda confusing but most drugs start out with what I like to call their chemical name and then later they get a commercial name. There are two big players on the anti-PD1 scene right now. One is BMS's drug which is nivolumab and is now being marketed as Opdivo. The second is Merck's pembrolizumab which is now being marketed as Keytruda. Both drugs are anti-PD1 inhibitors and both drugs have had very similar results on patients with maybe a slight edge to Keytruda but it's probably to early to say for sure. Hope this answers your question.
Brian
-
- February 10, 2015 at 6:29 pm
Crystal,
If I understand your question you are wondering in the first post by Jerry if the drug referred to as nivolumab is Keytruda. If that's your question the answer is no.
Kinda confusing but most drugs start out with what I like to call their chemical name and then later they get a commercial name. There are two big players on the anti-PD1 scene right now. One is BMS's drug which is nivolumab and is now being marketed as Opdivo. The second is Merck's pembrolizumab which is now being marketed as Keytruda. Both drugs are anti-PD1 inhibitors and both drugs have had very similar results on patients with maybe a slight edge to Keytruda but it's probably to early to say for sure. Hope this answers your question.
Brian
-
- February 10, 2015 at 7:12 am
Is this keytruda?
-
- February 5, 2015 at 8:01 pm
Yay! YAY! YAY! And a few….It's about time!!!! (s)!!!! Here's some data I've been YELLING to back up the approach if one is interested!! Thanks for sharing, Jerry!
Celeste
-
- You must be logged in to reply to this topic.